nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Rosuvastatin—atherosclerosis	0.0835	0.211	CbGbCtD
Tadalafil—CYP3A4—Ezetimibe—atherosclerosis	0.0835	0.211	CbGbCtD
Tadalafil—CYP3A4—Simvastatin—atherosclerosis	0.0776	0.196	CbGbCtD
Tadalafil—CYP3A4—Pravastatin—atherosclerosis	0.076	0.192	CbGbCtD
Tadalafil—CYP3A4—Lovastatin—atherosclerosis	0.076	0.192	CbGbCtD
Tadalafil—PDE5A—penis—atherosclerosis	0.0335	0.334	CbGeAlD
Tadalafil—PDE5A—artery—atherosclerosis	0.0155	0.155	CbGeAlD
Tadalafil—PDE5A—endothelium—atherosclerosis	0.0131	0.131	CbGeAlD
Tadalafil—PDE5A—blood vessel—atherosclerosis	0.0121	0.12	CbGeAlD
Tadalafil—PDE11A—liver—atherosclerosis	0.00876	0.0873	CbGeAlD
Tadalafil—PDE5A—connective tissue—atherosclerosis	0.0062	0.0617	CbGeAlD
Tadalafil—PDE5A—cardiovascular system—atherosclerosis	0.00539	0.0537	CbGeAlD
Tadalafil—PDE5A—adipose tissue—atherosclerosis	0.00475	0.0474	CbGeAlD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS2—atherosclerosis	0.00428	0.0357	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS2—atherosclerosis	0.00381	0.0318	CbGpPWpGaD
Tadalafil—PDE11A—Nitric oxide stimulates guanylate cyclase—NOS3—atherosclerosis	0.00344	0.0287	CbGpPWpGaD
Tadalafil—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00318	0.0265	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ESAM—atherosclerosis	0.00313	0.0261	CbGpPWpGaD
Tadalafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—atherosclerosis	0.00307	0.0256	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ESAM—atherosclerosis	0.00279	0.0233	CbGpPWpGaD
Tadalafil—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00228	0.019	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—APOB—atherosclerosis	0.00224	0.0186	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—APOB—atherosclerosis	0.00199	0.0166	CbGpPWpGaD
Tadalafil—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00197	0.0164	CbGpPWpGaD
Tadalafil—Bronchitis—Simvastatin—atherosclerosis	0.00185	0.00482	CcSEcCtD
Tadalafil—Abdominal discomfort—Simvastatin—atherosclerosis	0.00184	0.00481	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00182	0.00474	CcSEcCtD
Tadalafil—Nasopharyngitis—Pravastatin—atherosclerosis	0.0018	0.00469	CcSEcCtD
Tadalafil—Infestation—Ezetimibe—atherosclerosis	0.0018	0.00469	CcSEcCtD
Tadalafil—Infestation NOS—Ezetimibe—atherosclerosis	0.0018	0.00469	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00179	0.00466	CcSEcCtD
Tadalafil—Urinary tract infection—Lovastatin—atherosclerosis	0.00178	0.00465	CcSEcCtD
Tadalafil—Dysphagia—Niacin—atherosclerosis	0.00176	0.0046	CcSEcCtD
Tadalafil—Influenza—Niacin—atherosclerosis	0.00176	0.0046	CcSEcCtD
Tadalafil—Influenza—Pravastatin—atherosclerosis	0.00174	0.00453	CcSEcCtD
Tadalafil—Angina pectoris—Niacin—atherosclerosis	0.00172	0.00449	CcSEcCtD
Tadalafil—Mental disorder—Rosuvastatin—atherosclerosis	0.0017	0.00444	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.0017	0.00443	CcSEcCtD
Tadalafil—Bronchitis—Niacin—atherosclerosis	0.0017	0.00443	CcSEcCtD
Tadalafil—Angina pectoris—Pravastatin—atherosclerosis	0.00169	0.00442	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS2—atherosclerosis	0.00167	0.0139	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—OLR1—atherosclerosis	0.00165	0.0137	CbGpPWpGaD
Tadalafil—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00161	0.00421	CcSEcCtD
Tadalafil—Pharyngitis—Ezetimibe—atherosclerosis	0.0016	0.00418	CcSEcCtD
Tadalafil—Oedema peripheral—Ezetimibe—atherosclerosis	0.00159	0.00415	CcSEcCtD
Tadalafil—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00158	0.00414	CcSEcCtD
Tadalafil—Erythema multiforme—Lovastatin—atherosclerosis	0.00155	0.00406	CcSEcCtD
Tadalafil—Angioedema—Rosuvastatin—atherosclerosis	0.00154	0.00403	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00154	0.00401	CcSEcCtD
Tadalafil—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00153	0.00398	CcSEcCtD
Tadalafil—Flushing—Lovastatin—atherosclerosis	0.00153	0.00398	CcSEcCtD
Tadalafil—Erythema multiforme—Ezetimibe—atherosclerosis	0.00152	0.00398	CcSEcCtD
Tadalafil—Myocardial infarction—Pravastatin—atherosclerosis	0.00152	0.00396	CcSEcCtD
Tadalafil—Sweating—Niacin—atherosclerosis	0.00151	0.00394	CcSEcCtD
Tadalafil—Urinary tract infection—Pravastatin—atherosclerosis	0.00151	0.00393	CcSEcCtD
Tadalafil—Flushing—Ezetimibe—atherosclerosis	0.0015	0.00391	CcSEcCtD
Tadalafil—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00149	0.0124	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—NOS2—atherosclerosis	0.00149	0.0124	CbGpPWpGaD
Tadalafil—Cough—Rosuvastatin—atherosclerosis	0.00147	0.00385	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—OLR1—atherosclerosis	0.00147	0.0122	CbGpPWpGaD
Tadalafil—Angiopathy—Ezetimibe—atherosclerosis	0.00146	0.00382	CcSEcCtD
Tadalafil—Immune system disorder—Ezetimibe—atherosclerosis	0.00146	0.0038	CcSEcCtD
Tadalafil—Erythema multiforme—Simvastatin—atherosclerosis	0.00145	0.0038	CcSEcCtD
Tadalafil—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00145	0.00379	CcSEcCtD
Tadalafil—Myalgia—Rosuvastatin—atherosclerosis	0.00144	0.00375	CcSEcCtD
Tadalafil—Arthralgia—Rosuvastatin—atherosclerosis	0.00144	0.00375	CcSEcCtD
Tadalafil—Flushing—Simvastatin—atherosclerosis	0.00143	0.00373	CcSEcCtD
Tadalafil—Haemoglobin—Niacin—atherosclerosis	0.00142	0.0037	CcSEcCtD
Tadalafil—Rhinitis—Niacin—atherosclerosis	0.00142	0.00369	CcSEcCtD
Tadalafil—Mental disorder—Ezetimibe—atherosclerosis	0.00141	0.00369	CcSEcCtD
Tadalafil—Haemorrhage—Niacin—atherosclerosis	0.00141	0.00369	CcSEcCtD
Tadalafil—Hypoaesthesia—Niacin—atherosclerosis	0.00141	0.00367	CcSEcCtD
Tadalafil—Rhinitis—Pravastatin—atherosclerosis	0.00139	0.00364	CcSEcCtD
Tadalafil—Oedema peripheral—Niacin—atherosclerosis	0.00139	0.00363	CcSEcCtD
Tadalafil—Back pain—Lovastatin—atherosclerosis	0.00138	0.00361	CcSEcCtD
Tadalafil—Hypoaesthesia—Pravastatin—atherosclerosis	0.00138	0.00361	CcSEcCtD
Tadalafil—Pharyngitis—Pravastatin—atherosclerosis	0.00138	0.0036	CcSEcCtD
Tadalafil—Muscle spasms—Lovastatin—atherosclerosis	0.00138	0.00359	CcSEcCtD
Tadalafil—Infection—Rosuvastatin—atherosclerosis	0.00137	0.00357	CcSEcCtD
Tadalafil—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.00136	0.0114	CbGpPWpGaD
Tadalafil—Back pain—Ezetimibe—atherosclerosis	0.00136	0.00354	CcSEcCtD
Tadalafil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00135	0.00353	CcSEcCtD
Tadalafil—Muscle spasms—Ezetimibe—atherosclerosis	0.00135	0.00352	CcSEcCtD
Tadalafil—Vision blurred—Lovastatin—atherosclerosis	0.00135	0.00352	CcSEcCtD
Tadalafil—Mental disorder—Simvastatin—atherosclerosis	0.00135	0.00352	CcSEcCtD
Tadalafil—PDE11A—Platelet homeostasis—NOS3—atherosclerosis	0.00134	0.0112	CbGpPWpGaD
Tadalafil—Eye disorder—Niacin—atherosclerosis	0.00132	0.00344	CcSEcCtD
Tadalafil—Tinnitus—Niacin—atherosclerosis	0.00132	0.00344	CcSEcCtD
Tadalafil—Erythema multiforme—Pravastatin—atherosclerosis	0.00131	0.00343	CcSEcCtD
Tadalafil—Flushing—Niacin—atherosclerosis	0.00131	0.00342	CcSEcCtD
Tadalafil—Angioedema—Lovastatin—atherosclerosis	0.00131	0.00341	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SERPINC1—atherosclerosis	0.0013	0.0108	CbGpPWpGaD
Tadalafil—Tinnitus—Pravastatin—atherosclerosis	0.0013	0.00338	CcSEcCtD
Tadalafil—Cardiac disorder—Pravastatin—atherosclerosis	0.00129	0.00337	CcSEcCtD
Tadalafil—Flushing—Pravastatin—atherosclerosis	0.00129	0.00337	CcSEcCtD
Tadalafil—Muscle spasms—Simvastatin—atherosclerosis	0.00129	0.00336	CcSEcCtD
Tadalafil—Vertigo—Lovastatin—atherosclerosis	0.00129	0.00336	CcSEcCtD
Tadalafil—Angioedema—Ezetimibe—atherosclerosis	0.00128	0.00335	CcSEcCtD
Tadalafil—Angiopathy—Niacin—atherosclerosis	0.00128	0.00334	CcSEcCtD
Tadalafil—Vision blurred—Simvastatin—atherosclerosis	0.00126	0.00329	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00126	0.00328	CcSEcCtD
Tadalafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.00125	0.0104	CbGpPWpGaD
Tadalafil—Insomnia—Rosuvastatin—atherosclerosis	0.00125	0.00325	CcSEcCtD
Tadalafil—Palpitations—Ezetimibe—atherosclerosis	0.00124	0.00324	CcSEcCtD
Tadalafil—Paraesthesia—Rosuvastatin—atherosclerosis	0.00124	0.00323	CcSEcCtD
Tadalafil—Cough—Ezetimibe—atherosclerosis	0.00123	0.0032	CcSEcCtD
Tadalafil—Angioedema—Simvastatin—atherosclerosis	0.00122	0.00319	CcSEcCtD
Tadalafil—Arthralgia—Lovastatin—atherosclerosis	0.00122	0.00318	CcSEcCtD
Tadalafil—Myalgia—Lovastatin—atherosclerosis	0.00122	0.00318	CcSEcCtD
Tadalafil—Chest pain—Lovastatin—atherosclerosis	0.00122	0.00318	CcSEcCtD
Tadalafil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00121	0.00317	CcSEcCtD
Tadalafil—Hypertension—Ezetimibe—atherosclerosis	0.00121	0.00316	CcSEcCtD
Tadalafil—Discomfort—Lovastatin—atherosclerosis	0.0012	0.00314	CcSEcCtD
Tadalafil—Vertigo—Simvastatin—atherosclerosis	0.0012	0.00314	CcSEcCtD
Tadalafil—Chest pain—Ezetimibe—atherosclerosis	0.0012	0.00312	CcSEcCtD
Tadalafil—Myalgia—Ezetimibe—atherosclerosis	0.0012	0.00312	CcSEcCtD
Tadalafil—Arthralgia—Ezetimibe—atherosclerosis	0.0012	0.00312	CcSEcCtD
Tadalafil—PDE5A—Platelet homeostasis—NOS3—atherosclerosis	0.00119	0.00996	CbGpPWpGaD
Tadalafil—Dry mouth—Lovastatin—atherosclerosis	0.00119	0.00311	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00119	0.0031	CcSEcCtD
Tadalafil—Muscle spasms—Niacin—atherosclerosis	0.00118	0.00308	CcSEcCtD
Tadalafil—Discomfort—Ezetimibe—atherosclerosis	0.00118	0.00308	CcSEcCtD
Tadalafil—Constipation—Rosuvastatin—atherosclerosis	0.00118	0.00308	CcSEcCtD
Tadalafil—Pain—Rosuvastatin—atherosclerosis	0.00118	0.00308	CcSEcCtD
Tadalafil—Dry mouth—Ezetimibe—atherosclerosis	0.00117	0.00305	CcSEcCtD
Tadalafil—Muscle spasms—Pravastatin—atherosclerosis	0.00116	0.00304	CcSEcCtD
Tadalafil—Infection—Lovastatin—atherosclerosis	0.00116	0.00303	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SERPINC1—atherosclerosis	0.00116	0.00967	CbGpPWpGaD
Tadalafil—Vision blurred—Niacin—atherosclerosis	0.00116	0.00302	CcSEcCtD
Tadalafil—Vision blurred—Pravastatin—atherosclerosis	0.00114	0.00298	CcSEcCtD
Tadalafil—Myalgia—Simvastatin—atherosclerosis	0.00114	0.00297	CcSEcCtD
Tadalafil—Arthralgia—Simvastatin—atherosclerosis	0.00114	0.00297	CcSEcCtD
Tadalafil—Chest pain—Simvastatin—atherosclerosis	0.00114	0.00297	CcSEcCtD
Tadalafil—Infection—Ezetimibe—atherosclerosis	0.00114	0.00297	CcSEcCtD
Tadalafil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00113	0.00294	CcSEcCtD
Tadalafil—Discomfort—Simvastatin—atherosclerosis	0.00113	0.00294	CcSEcCtD
Tadalafil—Nervous system disorder—Ezetimibe—atherosclerosis	0.00112	0.00293	CcSEcCtD
Tadalafil—Angioedema—Niacin—atherosclerosis	0.00112	0.00293	CcSEcCtD
Tadalafil—Skin disorder—Ezetimibe—atherosclerosis	0.00111	0.0029	CcSEcCtD
Tadalafil—Angioedema—Pravastatin—atherosclerosis	0.00111	0.00289	CcSEcCtD
Tadalafil—Vertigo—Niacin—atherosclerosis	0.0011	0.00288	CcSEcCtD
Tadalafil—Syncope—Niacin—atherosclerosis	0.0011	0.00288	CcSEcCtD
Tadalafil—Urticaria—Rosuvastatin—atherosclerosis	0.0011	0.00286	CcSEcCtD
Tadalafil—Oedema—Simvastatin—atherosclerosis	0.00109	0.00285	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—F3—atherosclerosis	0.00109	0.00909	CbGpPWpGaD
Tadalafil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00109	0.00284	CcSEcCtD
Tadalafil—Vertigo—Pravastatin—atherosclerosis	0.00109	0.00284	CcSEcCtD
Tadalafil—Palpitations—Niacin—atherosclerosis	0.00109	0.00284	CcSEcCtD
Tadalafil—Infection—Simvastatin—atherosclerosis	0.00109	0.00283	CcSEcCtD
Tadalafil—Loss of consciousness—Niacin—atherosclerosis	0.00108	0.00282	CcSEcCtD
Tadalafil—Cough—Niacin—atherosclerosis	0.00107	0.0028	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00106	0.00278	CcSEcCtD
Tadalafil—Insomnia—Lovastatin—atherosclerosis	0.00106	0.00276	CcSEcCtD
Tadalafil—Cough—Pravastatin—atherosclerosis	0.00106	0.00276	CcSEcCtD
Tadalafil—Paraesthesia—Lovastatin—atherosclerosis	0.00105	0.00274	CcSEcCtD
Tadalafil—Arthralgia—Niacin—atherosclerosis	0.00105	0.00273	CcSEcCtD
Tadalafil—Myalgia—Niacin—atherosclerosis	0.00105	0.00273	CcSEcCtD
Tadalafil—Hypertension—Pravastatin—atherosclerosis	0.00104	0.00273	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00104	0.00272	CcSEcCtD
Tadalafil—Dyspnoea—Lovastatin—atherosclerosis	0.00104	0.00272	CcSEcCtD
Tadalafil—CYP3A4—liver—atherosclerosis	0.00104	0.0104	CbGeAlD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00104	0.00271	CcSEcCtD
Tadalafil—Insomnia—Ezetimibe—atherosclerosis	0.00104	0.0027	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—F5—atherosclerosis	0.00103	0.00862	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SELP—atherosclerosis	0.00103	0.00862	CbGpPWpGaD
Tadalafil—Arthralgia—Pravastatin—atherosclerosis	0.00103	0.00269	CcSEcCtD
Tadalafil—Chest pain—Pravastatin—atherosclerosis	0.00103	0.00269	CcSEcCtD
Tadalafil—Myalgia—Pravastatin—atherosclerosis	0.00103	0.00269	CcSEcCtD
Tadalafil—Paraesthesia—Ezetimibe—atherosclerosis	0.00103	0.00269	CcSEcCtD
Tadalafil—Dyspepsia—Lovastatin—atherosclerosis	0.00103	0.00268	CcSEcCtD
Tadalafil—Dry mouth—Niacin—atherosclerosis	0.00102	0.00267	CcSEcCtD
Tadalafil—Dyspnoea—Ezetimibe—atherosclerosis	0.00102	0.00267	CcSEcCtD
Tadalafil—Discomfort—Pravastatin—atherosclerosis	0.00102	0.00266	CcSEcCtD
Tadalafil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00102	0.00265	CcSEcCtD
Tadalafil—Dyspepsia—Ezetimibe—atherosclerosis	0.00101	0.00263	CcSEcCtD
Tadalafil—Fatigue—Lovastatin—atherosclerosis	0.00101	0.00263	CcSEcCtD
Tadalafil—Oedema—Niacin—atherosclerosis	0.001	0.00262	CcSEcCtD
Tadalafil—Pain—Lovastatin—atherosclerosis	0.000999	0.00261	CcSEcCtD
Tadalafil—Constipation—Lovastatin—atherosclerosis	0.000999	0.00261	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000995	0.0026	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000989	0.00258	CcSEcCtD
Tadalafil—Asthenia—Rosuvastatin—atherosclerosis	0.000989	0.00258	CcSEcCtD
Tadalafil—Insomnia—Simvastatin—atherosclerosis	0.000988	0.00258	CcSEcCtD
Tadalafil—Oedema—Pravastatin—atherosclerosis	0.000988	0.00258	CcSEcCtD
Tadalafil—Fatigue—Ezetimibe—atherosclerosis	0.000988	0.00258	CcSEcCtD
Tadalafil—Shock—Niacin—atherosclerosis	0.000987	0.00258	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CLU—atherosclerosis	0.000986	0.00822	CbGpPWpGaD
Tadalafil—Infection—Pravastatin—atherosclerosis	0.000981	0.00256	CcSEcCtD
Tadalafil—Paraesthesia—Simvastatin—atherosclerosis	0.000981	0.00256	CcSEcCtD
Tadalafil—Pain—Ezetimibe—atherosclerosis	0.00098	0.00256	CcSEcCtD
Tadalafil—Constipation—Ezetimibe—atherosclerosis	0.00098	0.00256	CcSEcCtD
Tadalafil—Tachycardia—Niacin—atherosclerosis	0.000979	0.00256	CcSEcCtD
Tadalafil—Pruritus—Rosuvastatin—atherosclerosis	0.000975	0.00255	CcSEcCtD
Tadalafil—Skin disorder—Niacin—atherosclerosis	0.000975	0.00254	CcSEcCtD
Tadalafil—Dyspnoea—Simvastatin—atherosclerosis	0.000974	0.00254	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—F3—atherosclerosis	0.000972	0.0081	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Niacin—atherosclerosis	0.00097	0.00253	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—HRH1—atherosclerosis	0.000967	0.00806	CbGpPWpGaD
Tadalafil—Dyspepsia—Simvastatin—atherosclerosis	0.000962	0.00251	CcSEcCtD
Tadalafil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000955	0.00249	CcSEcCtD
Tadalafil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000955	0.00249	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000944	0.00787	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000943	0.00246	CcSEcCtD
Tadalafil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000943	0.00246	CcSEcCtD
Tadalafil—Fatigue—Simvastatin—atherosclerosis	0.000942	0.00246	CcSEcCtD
Tadalafil—Hypotension—Niacin—atherosclerosis	0.000937	0.00245	CcSEcCtD
Tadalafil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000937	0.00245	CcSEcCtD
Tadalafil—Pain—Simvastatin—atherosclerosis	0.000934	0.00244	CcSEcCtD
Tadalafil—Constipation—Simvastatin—atherosclerosis	0.000934	0.00244	CcSEcCtD
Tadalafil—Urticaria—Lovastatin—atherosclerosis	0.000928	0.00242	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—THBD—atherosclerosis	0.000927	0.00773	CbGpPWpGaD
Tadalafil—Abdominal pain—Lovastatin—atherosclerosis	0.000923	0.00241	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SELP—atherosclerosis	0.000922	0.00768	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F5—atherosclerosis	0.000922	0.00768	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000914	0.00239	CcSEcCtD
Tadalafil—Dizziness—Rosuvastatin—atherosclerosis	0.000912	0.00238	CcSEcCtD
Tadalafil—Urticaria—Ezetimibe—atherosclerosis	0.00091	0.00238	CcSEcCtD
Tadalafil—Insomnia—Niacin—atherosclerosis	0.000907	0.00237	CcSEcCtD
Tadalafil—Abdominal pain—Ezetimibe—atherosclerosis	0.000906	0.00236	CcSEcCtD
Tadalafil—Paraesthesia—Niacin—atherosclerosis	0.000901	0.00235	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0009	0.00235	CcSEcCtD
Tadalafil—Dyspnoea—Niacin—atherosclerosis	0.000894	0.00233	CcSEcCtD
Tadalafil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000893	0.00233	CcSEcCtD
Tadalafil—Insomnia—Pravastatin—atherosclerosis	0.000893	0.00233	CcSEcCtD
Tadalafil—Somnolence—Niacin—atherosclerosis	0.000892	0.00233	CcSEcCtD
Tadalafil—Paraesthesia—Pravastatin—atherosclerosis	0.000887	0.00232	CcSEcCtD
Tadalafil—Dyspepsia—Niacin—atherosclerosis	0.000883	0.0023	CcSEcCtD
Tadalafil—Dyspnoea—Pravastatin—atherosclerosis	0.000881	0.0023	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SELE—atherosclerosis	0.000879	0.00733	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CLU—atherosclerosis	0.000879	0.00733	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRH1—atherosclerosis	0.000878	0.00732	CbGpPWpGaD
Tadalafil—Dyspepsia—Pravastatin—atherosclerosis	0.00087	0.00227	CcSEcCtD
Tadalafil—Rash—Rosuvastatin—atherosclerosis	0.000869	0.00227	CcSEcCtD
Tadalafil—Dermatitis—Rosuvastatin—atherosclerosis	0.000868	0.00227	CcSEcCtD
Tadalafil—Urticaria—Simvastatin—atherosclerosis	0.000868	0.00227	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000866	0.00226	CcSEcCtD
Tadalafil—Abdominal pain—Simvastatin—atherosclerosis	0.000864	0.00225	CcSEcCtD
Tadalafil—Headache—Rosuvastatin—atherosclerosis	0.000864	0.00225	CcSEcCtD
Tadalafil—Hypersensitivity—Lovastatin—atherosclerosis	0.000861	0.00225	CcSEcCtD
Tadalafil—Pain—Niacin—atherosclerosis	0.000858	0.00224	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000856	0.00713	CbGpPWpGaD
Tadalafil—Fatigue—Pravastatin—atherosclerosis	0.000852	0.00222	CcSEcCtD
Tadalafil—Constipation—Pravastatin—atherosclerosis	0.000845	0.0022	CcSEcCtD
Tadalafil—Pain—Pravastatin—atherosclerosis	0.000845	0.0022	CcSEcCtD
Tadalafil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000844	0.0022	CcSEcCtD
Tadalafil—Asthenia—Lovastatin—atherosclerosis	0.000838	0.00219	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—THBD—atherosclerosis	0.000827	0.00689	CbGpPWpGaD
Tadalafil—Pruritus—Lovastatin—atherosclerosis	0.000826	0.00216	CcSEcCtD
Tadalafil—Asthenia—Ezetimibe—atherosclerosis	0.000822	0.00215	CcSEcCtD
Tadalafil—Gastrointestinal pain—Niacin—atherosclerosis	0.00082	0.00214	CcSEcCtD
Tadalafil—Nausea—Rosuvastatin—atherosclerosis	0.000819	0.00214	CcSEcCtD
Tadalafil—Pruritus—Ezetimibe—atherosclerosis	0.000811	0.00212	CcSEcCtD
Tadalafil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000808	0.00211	CcSEcCtD
Tadalafil—Hypersensitivity—Simvastatin—atherosclerosis	0.000805	0.0021	CcSEcCtD
Tadalafil—Diarrhoea—Lovastatin—atherosclerosis	0.000799	0.00209	CcSEcCtD
Tadalafil—Urticaria—Niacin—atherosclerosis	0.000797	0.00208	CcSEcCtD
Tadalafil—Abdominal pain—Niacin—atherosclerosis	0.000793	0.00207	CcSEcCtD
Tadalafil—Urticaria—Pravastatin—atherosclerosis	0.000785	0.00205	CcSEcCtD
Tadalafil—Asthenia—Simvastatin—atherosclerosis	0.000784	0.00205	CcSEcCtD
Tadalafil—Diarrhoea—Ezetimibe—atherosclerosis	0.000784	0.00205	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—VWF—atherosclerosis	0.000784	0.00653	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SELE—atherosclerosis	0.000784	0.00653	CbGpPWpGaD
Tadalafil—Abdominal pain—Pravastatin—atherosclerosis	0.000781	0.00204	CcSEcCtD
Tadalafil—Pruritus—Simvastatin—atherosclerosis	0.000773	0.00202	CcSEcCtD
Tadalafil—Dizziness—Lovastatin—atherosclerosis	0.000772	0.00202	CcSEcCtD
Tadalafil—Dizziness—Ezetimibe—atherosclerosis	0.000758	0.00198	CcSEcCtD
Tadalafil—Diarrhoea—Simvastatin—atherosclerosis	0.000748	0.00195	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—F7—atherosclerosis	0.000748	0.00623	CbGpPWpGaD
Tadalafil—Vomiting—Lovastatin—atherosclerosis	0.000743	0.00194	CcSEcCtD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000741	0.00617	CbGpPWpGaD
Tadalafil—Hypersensitivity—Niacin—atherosclerosis	0.000739	0.00193	CcSEcCtD
Tadalafil—Rash—Lovastatin—atherosclerosis	0.000737	0.00192	CcSEcCtD
Tadalafil—Dermatitis—Lovastatin—atherosclerosis	0.000736	0.00192	CcSEcCtD
Tadalafil—Headache—Lovastatin—atherosclerosis	0.000732	0.00191	CcSEcCtD
Tadalafil—Vomiting—Ezetimibe—atherosclerosis	0.000728	0.0019	CcSEcCtD
Tadalafil—Hypersensitivity—Pravastatin—atherosclerosis	0.000728	0.0019	CcSEcCtD
Tadalafil—Dizziness—Simvastatin—atherosclerosis	0.000723	0.00189	CcSEcCtD
Tadalafil—Rash—Ezetimibe—atherosclerosis	0.000722	0.00189	CcSEcCtD
Tadalafil—Dermatitis—Ezetimibe—atherosclerosis	0.000722	0.00188	CcSEcCtD
Tadalafil—Asthenia—Niacin—atherosclerosis	0.00072	0.00188	CcSEcCtD
Tadalafil—Headache—Ezetimibe—atherosclerosis	0.000718	0.00187	CcSEcCtD
Tadalafil—Pruritus—Niacin—atherosclerosis	0.00071	0.00185	CcSEcCtD
Tadalafil—Asthenia—Pravastatin—atherosclerosis	0.000709	0.00185	CcSEcCtD
Tadalafil—Pruritus—Pravastatin—atherosclerosis	0.000699	0.00182	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—VWF—atherosclerosis	0.000698	0.00582	CbGpPWpGaD
Tadalafil—Vomiting—Simvastatin—atherosclerosis	0.000695	0.00181	CcSEcCtD
Tadalafil—Nausea—Lovastatin—atherosclerosis	0.000694	0.00181	CcSEcCtD
Tadalafil—Rash—Simvastatin—atherosclerosis	0.000689	0.0018	CcSEcCtD
Tadalafil—Dermatitis—Simvastatin—atherosclerosis	0.000688	0.0018	CcSEcCtD
Tadalafil—Diarrhoea—Niacin—atherosclerosis	0.000686	0.00179	CcSEcCtD
Tadalafil—Headache—Simvastatin—atherosclerosis	0.000684	0.00179	CcSEcCtD
Tadalafil—Nausea—Ezetimibe—atherosclerosis	0.000681	0.00178	CcSEcCtD
Tadalafil—Diarrhoea—Pravastatin—atherosclerosis	0.000676	0.00176	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PLAT—atherosclerosis	0.000666	0.00555	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F7—atherosclerosis	0.000666	0.00555	CbGpPWpGaD
Tadalafil—Dizziness—Niacin—atherosclerosis	0.000663	0.00173	CcSEcCtD
Tadalafil—Dizziness—Pravastatin—atherosclerosis	0.000653	0.0017	CcSEcCtD
Tadalafil—Nausea—Simvastatin—atherosclerosis	0.000649	0.00169	CcSEcCtD
Tadalafil—Vomiting—Niacin—atherosclerosis	0.000638	0.00166	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCL4—atherosclerosis	0.000635	0.00529	CbGpPWpGaD
Tadalafil—Rash—Niacin—atherosclerosis	0.000633	0.00165	CcSEcCtD
Tadalafil—Dermatitis—Niacin—atherosclerosis	0.000632	0.00165	CcSEcCtD
Tadalafil—Headache—Niacin—atherosclerosis	0.000629	0.00164	CcSEcCtD
Tadalafil—Vomiting—Pravastatin—atherosclerosis	0.000628	0.00164	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—UTS2—atherosclerosis	0.000623	0.0052	CbGpPWpGaD
Tadalafil—Rash—Pravastatin—atherosclerosis	0.000623	0.00163	CcSEcCtD
Tadalafil—Dermatitis—Pravastatin—atherosclerosis	0.000622	0.00162	CcSEcCtD
Tadalafil—Headache—Pravastatin—atherosclerosis	0.000619	0.00162	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CASR—atherosclerosis	0.000598	0.00498	CbGpPWpGaD
Tadalafil—Nausea—Niacin—atherosclerosis	0.000596	0.00156	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PLAT—atherosclerosis	0.000594	0.00495	CbGpPWpGaD
Tadalafil—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000588	0.0049	CbGpPWpGaD
Tadalafil—Nausea—Pravastatin—atherosclerosis	0.000587	0.00153	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—KNG1—atherosclerosis	0.000585	0.00487	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAUR—atherosclerosis	0.00058	0.00483	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLG—atherosclerosis	0.000567	0.00472	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—UTS2—atherosclerosis	0.000566	0.00472	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CNR2—atherosclerosis	0.000556	0.00463	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000543	0.00453	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SOD1—atherosclerosis	0.000543	0.00453	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000543	0.00452	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CASR—atherosclerosis	0.000543	0.00452	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000536	0.00447	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000532	0.00444	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KNG1—atherosclerosis	0.000521	0.00434	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRH1—atherosclerosis	0.000519	0.00433	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAUR—atherosclerosis	0.000517	0.00431	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF2—atherosclerosis	0.000516	0.0043	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLG—atherosclerosis	0.000505	0.00421	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CNR2—atherosclerosis	0.000505	0.00421	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000502	0.00419	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APOB—atherosclerosis	0.000501	0.00417	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000496	0.00413	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SOD1—atherosclerosis	0.000484	0.00403	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCG—atherosclerosis	0.000465	0.00387	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF2—atherosclerosis	0.00046	0.00383	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CD36—atherosclerosis	0.000454	0.00379	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APOB—atherosclerosis	0.000446	0.00372	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000442	0.00368	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00044	0.00367	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL3—atherosclerosis	0.000434	0.00362	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000432	0.0036	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR2—atherosclerosis	0.000432	0.0036	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—GHRL—atherosclerosis	0.000421	0.00351	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PDGFB—atherosclerosis	0.000419	0.00349	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCG—atherosclerosis	0.000414	0.00345	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MMP1—atherosclerosis	0.000414	0.00345	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA4—atherosclerosis	0.000407	0.00339	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000407	0.00339	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CD36—atherosclerosis	0.000405	0.00338	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CAV1—atherosclerosis	0.000397	0.00331	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APOA1—atherosclerosis	0.000396	0.0033	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDNRA—atherosclerosis	0.000392	0.00327	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR2—atherosclerosis	0.000392	0.00327	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GHRL—atherosclerosis	0.000382	0.00319	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—F2—atherosclerosis	0.000378	0.00315	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL4—atherosclerosis	0.000375	0.00313	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—atherosclerosis	0.000374	0.00311	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PDGFB—atherosclerosis	0.000374	0.00311	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—KNG1—atherosclerosis	0.00037	0.00308	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MMP1—atherosclerosis	0.000369	0.00308	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000367	0.00306	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CG—atherosclerosis	0.000362	0.00301	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CAV1—atherosclerosis	0.000354	0.00295	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APOA1—atherosclerosis	0.000353	0.00294	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA2—atherosclerosis	0.000351	0.00292	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F2—atherosclerosis	0.000337	0.00281	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KNG1—atherosclerosis	0.000336	0.0028	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—UTS2—atherosclerosis	0.000334	0.00279	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGTR1—atherosclerosis	0.000334	0.00278	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—atherosclerosis	0.000333	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IGF1—atherosclerosis	0.000331	0.00276	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CG—atherosclerosis	0.000322	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CX3CR1—atherosclerosis	0.000321	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASR—atherosclerosis	0.000321	0.00267	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SERPINE1—atherosclerosis	0.000315	0.00262	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CX3CL1—atherosclerosis	0.000314	0.00262	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ALB—atherosclerosis	0.000314	0.00262	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—EDN1—atherosclerosis	0.000311	0.0026	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCL5—atherosclerosis	0.000309	0.00258	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000306	0.00255	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS3—atherosclerosis	0.0003	0.0025	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CNR2—atherosclerosis	0.000298	0.00248	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MMP3—atherosclerosis	0.000297	0.00248	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IGF1—atherosclerosis	0.000295	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000294	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EDN1—atherosclerosis	0.000283	0.00236	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL5—atherosclerosis	0.000281	0.00234	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SERPINE1—atherosclerosis	0.00028	0.00234	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ALB—atherosclerosis	0.00028	0.00233	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS3—atherosclerosis	0.000268	0.00223	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCG—atherosclerosis	0.000267	0.00222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VWF—atherosclerosis	0.000266	0.00221	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOC3—atherosclerosis	0.000264	0.0022	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LDLR—atherosclerosis	0.000262	0.00219	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—atherosclerosis	0.000259	0.00215	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL3—atherosclerosis	0.000256	0.00214	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000253	0.00211	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NCF1—atherosclerosis	0.000245	0.00205	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2—atherosclerosis	0.000239	0.00199	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AGT—atherosclerosis	0.000235	0.00196	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000234	0.00195	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR2—atherosclerosis	0.000232	0.00193	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDNRA—atherosclerosis	0.000232	0.00193	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CYBA—atherosclerosis	0.000231	0.00192	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000231	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000229	0.00191	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PARP1—atherosclerosis	0.000226	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GHRL—atherosclerosis	0.000226	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLAT—atherosclerosis	0.000226	0.00188	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2—atherosclerosis	0.000217	0.00181	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—atherosclerosis	0.000216	0.0018	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000216	0.0018	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000213	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000208	0.00173	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MAPK3—atherosclerosis	0.000205	0.00171	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TGFB1—atherosclerosis	0.000199	0.00165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KNG1—atherosclerosis	0.000198	0.00165	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGTR1—atherosclerosis	0.000197	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—atherosclerosis	0.000193	0.00161	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—atherosclerosis	0.000193	0.00161	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PLG—atherosclerosis	0.000192	0.0016	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK3—atherosclerosis	0.000182	0.00152	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS3—atherosclerosis	0.000182	0.00152	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TGFB1—atherosclerosis	0.000177	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP3—atherosclerosis	0.000176	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF2—atherosclerosis	0.000175	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOB—atherosclerosis	0.00017	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000168	0.0014	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EDN1—atherosclerosis	0.000167	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL5—atherosclerosis	0.000166	0.00138	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LPL—atherosclerosis	0.000162	0.00135	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCG—atherosclerosis	0.000158	0.00131	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPP1—atherosclerosis	0.000154	0.00128	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—atherosclerosis	0.000153	0.00127	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFB—atherosclerosis	0.000142	0.00118	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—atherosclerosis	0.000139	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—atherosclerosis	0.000138	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LEP—atherosclerosis	0.000136	0.00113	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—atherosclerosis	0.000136	0.00113	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CAV1—atherosclerosis	0.000135	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOA1—atherosclerosis	0.000134	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ESR1—atherosclerosis	0.00013	0.00108	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—atherosclerosis	0.000128	0.00107	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—atherosclerosis	0.000123	0.00103	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—atherosclerosis	0.000123	0.00102	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAPK3—atherosclerosis	0.000117	0.000979	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—INS—atherosclerosis	0.000116	0.000968	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—atherosclerosis	0.000114	0.000952	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IGF1—atherosclerosis	0.000112	0.000936	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SERPINE1—atherosclerosis	0.000107	0.000889	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOS3—atherosclerosis	0.000102	0.000848	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	9.66e-05	0.000805	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	9.53e-05	0.000794	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—atherosclerosis	9.03e-05	0.000753	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—atherosclerosis	8.72e-05	0.000727	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—atherosclerosis	8.59e-05	0.000716	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—atherosclerosis	8.17e-05	0.000681	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NFKB1—atherosclerosis	8.08e-05	0.000674	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK8—atherosclerosis	7.94e-05	0.000662	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—atherosclerosis	7.92e-05	0.00066	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—atherosclerosis	7.33e-05	0.000611	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—atherosclerosis	7.26e-05	0.000605	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK3—atherosclerosis	6.94e-05	0.000578	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	6.85e-05	0.000571	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TGFB1—atherosclerosis	6.73e-05	0.000561	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLTP—atherosclerosis	6.44e-05	0.000537	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.58e-05	0.000465	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.58e-05	0.000465	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—atherosclerosis	5.07e-05	0.000423	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—atherosclerosis	4.68e-05	0.00039	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.41e-05	0.000368	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LCAT—atherosclerosis	4.15e-05	0.000346	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FABP4—atherosclerosis	4.15e-05	0.000346	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA4—atherosclerosis	4.07e-05	0.000339	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4e-05	0.000333	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.7e-05	0.000308	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.51e-05	0.000292	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA2—atherosclerosis	3.51e-05	0.000292	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.51e-05	0.000292	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.51e-05	0.000292	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.46e-05	0.000289	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPA—atherosclerosis	3.34e-05	0.000279	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BGN—atherosclerosis	3.24e-05	0.00027	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA5—atherosclerosis	3.21e-05	0.000267	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.09e-05	0.000257	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.98e-05	0.000248	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.67e-05	0.000223	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LIPC—atherosclerosis	2.66e-05	0.000221	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOC3—atherosclerosis	2.64e-05	0.00022	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LDLR—atherosclerosis	2.62e-05	0.000219	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CETP—atherosclerosis	2.56e-05	0.000214	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.45e-05	0.000205	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.32e-05	0.000193	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.07e-05	0.000172	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.77e-05	0.000148	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOB—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.65e-05	0.000138	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—LPL—atherosclerosis	1.62e-05	0.000135	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX1—atherosclerosis	1.58e-05	0.000132	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CD36—atherosclerosis	1.54e-05	0.000128	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.000122	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARA—atherosclerosis	1.43e-05	0.000119	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—atherosclerosis	1.36e-05	0.000113	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—atherosclerosis	1.35e-05	0.000112	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—atherosclerosis	1.34e-05	0.000112	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—atherosclerosis	1.18e-05	9.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—INS—atherosclerosis	1.16e-05	9.68e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—atherosclerosis	1.06e-05	8.87e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NOS3—atherosclerosis	1.02e-05	8.49e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.31e-06	7.76e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—atherosclerosis	4.68e-06	3.9e-05	CbGpPWpGaD
